Pinned Tweet
Final print of BCLC 2025 available at authors.elsevier.com/c/1mZTW… A team effort by BCLC members and external experts. Incorporation of CUSE concepts into the MTBoard allows personalised recommendations @hospitalclinic @idibaps @EASLnews @ILCAnews @AEEHLiver @ContraCancerEs
Please note the liver connection between Barcelona and Naples in the figure. Now fully consolidated because of the faculty status of @MarcoSanduzzi
1st International activity of the Liver Cancer Chair of the @UniBarcelona takes place in Naples. Sharing experience and knowledge. An optimal way to celebrate the #livercancerawarenessmonth @hospitalclinic @idibaps
1st International activity of the Liver Cancer Chair of the @UniBarcelona takes place in Naples. Sharing experience and knowledge. An optimal way to celebrate the #livercancerawarenessmonth @hospitalclinic @idibaps
October is Liver Cancer Awareness Month 🎗️
We stand with the ILCA Advocacy Committee & global experts to elevate care, share vital insights, and bridge gaps in policy, prevention, and patient support.
Learn more on how to join us: ilcalive.org/wp-content/uplo…
The #BCLC2026 conversation doesn’t start on November 16 — and it doesn’t end on November 17.
✨ Introducing the BCLC 2026 Scientific Exchange, a dedicated space for registered participants to connect, discuss and engage with the science before and after the meeting.
Here you have the link to join the action and enjoy interaction while macimizing the acquisition of knowledge.
update.bclc.cat/bclc2026/en/…
🔬 Explore scientific resources
💬 Join the discussion
🤝 Exchange perspectives
🎥 Revisit key sessions after the congress
The meeting lasts two days. The scientific conversation goes far beyond.
Welcome to the BCLC Update 2026 Scientific Exchange.
🔴Avui és el #DiaMundialRecercaCàncer
Al @hospitalclinic-#IDIBAPS investiguem per entendre millor el càncer, prevenir-lo, diagnosticar-lo abans i desenvolupar tractaments més precisos
👉f.mtr.cool/ch13rvv6jd
🧵 Repassem alguns dels avenços en recerca de l’últim any 👇
Two months to go! A very promising event with international KOLs to debate all the information released in the last 12 months. Program at
docs.academia.cat/mailing/16…
Registration at inscripcions.academia.cat/fo…
@hospitalclinic @idibaps @AEEHLiver @ContraCancerEs @ILCAnews
The CUSE concept serves the need to recommend the optimal therapy for an individual patient.
An honor to have it supported in China.
@hospitalclinic @idibaps @EASLnews @ILCAnews
Was not easy to find the time slot to take the picture of the BCLC members attending @ILCAnews: @ma5RN @martafortuny10 @nllarch @MarcoSanduzzi & @bruixj Happiness at work is a privilege! What else! @hospitalclinic @idibaps
20 years of activity mean maturity and great future. Great to see @ma5RN @MarcoSanduzzi and @bruixj from the BCLC in the picture. Transgeneration involvement!!
The wait is over #ILCA26!
Opened by President Prof. Stephen Lam Chan with a special tribute to past leaders, Day 1 featured key updates on Bench to Bedside care, the Asian experience and joint KLCA surgical session.
Day 2 continues today!
🔗 ilcalive.org/annual-conferen…
Successful advocacy task by @ILCAnews organised by @allaire_manon A call to action on liver cancer raised through a document to be debated at the European level. It will be open for comments at the ILCA website. A needed development.
Informative and patient centered messages by @ma5RN and @nllarch at @ILCAnews 2026. Scientific evidence and patients needs drive the group philosophy. @hospitalclinic @idibaps
The Pan-Asian adapted ESMO CPGs for HCC DOI: 10.1016/j.esmoop.2025.105826 endorse the BCLC for prognosis & treatment recommendations. The modulations mimic the BCLC update with CUSE concept pubmed.ncbi.nlm.nih.gov/4115… The start of a global consensus.
@hospitalclinic @idibaps
🆕An international study led by #CLÍNIC-#IDIBAPS shows that external beam radiotherapy can offer survival outcomes comparable to those of current local treatments for hepatocellular carcinoma, the most common type of liver cancer
👉f.mtr.cool/wczzrlljqj
BCLC GROUP retweeted
📊 La radioteràpia externa pot oferir una supervivència similar als tractaments locals establerts en el càncer de fetge, especialment en estadis inicials.
🔹Aquesta és una de les conclusions d’un estudi internacional amb dades de prop de 5️⃣0️⃣0️⃣0️⃣ pacients, el més ampli fet fins a la data en aquest àmbit.
🔹L'ha coordinat la Unitat d’Oncologia Hepàtica @BCLC_group del #CLÍNIC-@idibaps, en el marc del #ClínicBarcelonaComprehensiveCancerCentre.
👉clinicbarcelona.org/ca/notic…
Clinical practice forces us to face the complexity of decision making to reach an optimal recommendation. This is the reason to develop the bclccuse.ai/ to inform decisions. All presented by @ma5RN also at the Shanghai APPLE meeting @hospitalclinic @idibaps
Selecting appropriate strategy #HCC
@ma5RN giving fabulous BCLC overview- navigating early/intermediate
➡️combos no OS benefit to date
➡️Using CUSE & available evidence to help select tools at MDT
➡️noting the ‘real world’ patient & the patient preference
#ESMOGI26 @OncoAlert
🎙️ The new Y-ILCA Podcast is officially live!
Ep. 1: Trailblazers in Liver Cancer
Join host Dr. Joana Espírito Santo in conversation with a true legend: Prof. Jordi Bruix, ILCA Co-Founder & BCLC creator.
🔗Listen to the premiere episode: open.spotify.com/episode/6Zv…
Today Carla Fuster MD obtained her PhD after a brilliant exposure of pathology profiling of liver cancer. Great work mentored by @ma5RN & Prof Alba Diaz. A promising career ahead. Colleagues and family are proud and happy!! @hospitalclinic @idibaps @APClinicBCN
Our BCLC senior radiologist Prof Carmen Ayuso was awarded today the Honorary Fellowship by @EsgarSociety Big recognition to a fruitful career. @hospitalclinic @idibaps @ContraCancerEs @SERAM_RX @myESR @RXabdominalHCB






































